1. The biotech resurrection continues — Industry and FDA begin to hammer out PDUFA VII details — JNJ single-shot COVID-19 vaccine shows early promise — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

FORTIVE

Discussion in 'Johnson & Johnson' started by anonymous, Oct 29, 2018 at 11:20 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    OMG. I cannot wait til next quarter. The suspense is killing me!!
     

  2. anonymous

    anonymous Guest

    Nothing will happen.
     
  3. anonymous

    anonymous Guest

    Do people care about ASP?
     
  4. anonymous

    anonymous Guest

    Who’s head rolls next? Place your bets here...
     
  5. anonymous

    anonymous Guest

    wow I actually thought things couldn’t get any worse at Fortive compared to J&J.
     
  6. anonymous

    anonymous Guest

    CPS positions will be reduced, those remaining will have expanded or focused territories and new call points( surgery centers) .It is not feasible to pay both AM/CPS for consumables at same acute account. Elimination of CADs as they defined now, possibly into smaller mini cad positions like they have on west & east coast.
     
  7. anonymous

    anonymous Guest

     
  8. anonymous

    anonymous Guest

    Now everyone is a capital rep with a lower comp...they have no clue whats going on.
     
  9. anonymous

    anonymous Guest

    J&J Surgical Vision sales were down 9% in 2019. Alarmingly, US sales were down 15% in Q4 of 2019. When Abbott owned this business it was always growing. Shlomi is sucking the life out of this business to fund Biosense.
     
  10. anonymous

    anonymous Guest

    Total dumpster fire at ASP.
     
  11. anonymous

    anonymous Guest

    How is this working out?
     
  12. anonymous

    anonymous Guest

    Runnnnn!
     
  13. anonymous

    anonymous Guest